Rodney Gonsalves Sells 1,908 Shares of Agilent Technologies, Inc. (NYSE:A) Stock

Agilent Technologies, Inc. (NYSE:A - Get Free Report) VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Agilent Technologies Stock Performance

Agilent Technologies stock traded up $0.44 during trading on Friday, reaching $120.72. The company had a trading volume of 3,041,425 shares, compared to its average volume of 1,682,117. Agilent Technologies, Inc. has a 52 week low of $117.17 and a 52 week high of $155.35. The firm's 50-day simple moving average is $136.74 and its 200 day simple moving average is $137.30. The firm has a market capitalization of $34.42 billion, a price-to-earnings ratio of 27.75, a price-to-earnings-growth ratio of 3.38 and a beta of 1.11. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Remove Ads

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.82%. Agilent Technologies's dividend payout ratio is presently 22.76%.

Institutional Investors Weigh In On Agilent Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. CKW Financial Group increased its holdings in shares of Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after purchasing an additional 100 shares during the last quarter. Global X Japan Co. Ltd. increased its holdings in shares of Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after purchasing an additional 116 shares during the last quarter. Redwood Park Advisors LLC bought a new stake in shares of Agilent Technologies in the fourth quarter worth about $27,000. Lee Danner & Bass Inc. bought a new stake in shares of Agilent Technologies in the fourth quarter worth about $29,000. Finally, Sunbelt Securities Inc. increased its holdings in shares of Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after purchasing an additional 192 shares during the last quarter.

Analysts Set New Price Targets

A has been the topic of a number of analyst reports. Bank of America decreased their price objective on Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a research note on Friday, December 13th. Sanford C. Bernstein reduced their target price on Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating for the company in a research report on Tuesday, November 26th. Barclays upgraded Agilent Technologies from an "underweight" rating to an "equal weight" rating and increased their target price for the company from $135.00 to $145.00 in a report on Monday, February 10th. StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. Finally, Robert W. Baird cut their price target on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research note on Thursday, February 27th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of "Moderate Buy" and an average target price of $146.15.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.